AACR 2026: ADC Post-Conference Report
Prepared by the Beacon ADC analyst team, the AACR 2026 ADC Post‑Conference Report supports researchers, strategists, and competitive intelligence teams assessing the ADC landscape following the meeting in San Diego. Beacon analysts reviewed the full AACR 2026 abstract set and identified 373 ADC‑relevant presentations, synthesizing them into a focused, analyst‑reviewed resource designed for post‑conference analysis and strategic decision‑making.
What to Expect?
- ADC conference coverage: A complete analysis of all 373 ADC‑relevant abstracts, removing the need to manually review the full AACR programme.
- Clinical and preclinical insights: Structured summaries of key research, including 119 newly disclosed ADC assets across development stages.
- Emerging targets and modalities: Insight into growing focus areas such as novel targets and next‑generation ADC formats, including bispecific and degrader‑based approaches.
- Post‑AACR strategic context: Clear synthesis to support pipeline benchmarking, target prioritization, and competitive positioning.
You May Also Be Interested In…
Learn More About ADC
- The Most Comprehensive Way to Search the ADC Drug Development Landscape: Unique search ontologies based on ADC drug and trial characteristics
- Market Leading Approach to ADC Preclinical & Clinical Data Curation: Manual curation of key ADC research and development data points by ADC research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search ADC company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.
Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements
